Tags

Type your tag names separated by a space and hit enter

[Asthma and COPD management during the COVID-19 pandemic].
Rev Med Suisse. 2020 May 06; 16(692):933-938.RM

Abstract

Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.

Authors+Show Affiliations

Service de pneumologie, Département de médecine, CHUV, 1011 Lausanne.Service de pneumologie, Département de médecine, CHUV, 1011 Lausanne.Service de pneumologie, Département de médecine, CHUV, 1011 Lausanne.

Pub Type(s)

Journal Article

Language

fre

PubMed ID

32374540

Citation

Daccord, Cécile, et al. "[Asthma and COPD Management During the COVID-19 Pandemic]." Revue Medicale Suisse, vol. 16, no. 692, 2020, pp. 933-938.
Daccord C, Touilloux B, Von Garnier C. [Asthma and COPD management during the COVID-19 pandemic]. Rev Med Suisse. 2020;16(692):933-938.
Daccord, C., Touilloux, B., & Von Garnier, C. (2020). [Asthma and COPD management during the COVID-19 pandemic]. Revue Medicale Suisse, 16(692), 933-938.
Daccord C, Touilloux B, Von Garnier C. [Asthma and COPD Management During the COVID-19 Pandemic]. Rev Med Suisse. 2020 May 6;16(692):933-938. PubMed PMID: 32374540.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Asthma and COPD management during the COVID-19 pandemic]. AU - Daccord,Cécile, AU - Touilloux,Brice, AU - Von Garnier,Christophe, PY - 2020/5/7/entrez PY - 2020/5/7/pubmed PY - 2020/5/10/medline SP - 933 EP - 938 JF - Revue medicale suisse JO - Rev Med Suisse VL - 16 IS - 692 N2 - Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease. SN - 1660-9379 UR - https://www.unboundmedicine.com/medline/citation/32374540/[Asthma_and_COPD_management_during_the_COVID_19_pandemic]_ DB - PRIME DP - Unbound Medicine ER -